Richard Gonzalez, AbbVie CEO (Chris Kleponis via AP Images)
March 31, 2022 02:20 PM EDTUpdated April 1, 10:28 AM
Pharma

Rick Gon­za­lez stays in the win­ners cir­cle at Ab­b­Vie, grab­bing $24M comp pack­age

John Carroll

Editor & Founder

Hu­mi­ra hit an­oth­er big record in megablock­buster his­to­ry in 2021, break­ing the $20 bil­lion mark in sales and steer­ing the com­pa­ny to a stel­lar 22 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times